Visual function changes in a Parkinson's Disease cohort - preliminary data.
Vlad-Ioan Suciu1, Corina-Iuliana Suciu2, Simona Delia Nicoară3
1Department of Neuroscience, "Iuliu Haţieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Romanian Journal of Ophthalmology
|January 17, 2022
Summary
Parkinson's disease (PD) is a growing global health concern, affecting over 6 million people. Early recognition and intervention are crucial for improving the quality of life for those with PD.
Area of Science:
- Neurodegenerative disorders
- Neurology
- Public Health
Background:
- Parkinson's disease (PD) is the second most common neurodegenerative disorder.
- Global prevalence of PD has significantly increased, rising from 2.5 million in 1990 to 6.1 million in 2016.
- PD is increasingly viewed as a syndrome with complex features beyond motor symptoms.
Purpose of the Study:
- To highlight the growing global prevalence of Parkinson's disease.
- To emphasize the importance of non-motor symptoms in early PD diagnosis.
- To advocate for increased public awareness, early recognition, and neuroprotective interventions for PD.
Main Methods:
- The abstract does not specify methods but discusses prevalence data and diagnostic criteria.
- Analysis of global prevalence trends from 1990 to 2016.
- Inclusion of non-motor features in current diagnostic criteria.
Main Results:
- Worldwide prevalence of Parkinson's disease (PD) has dramatically increased.
- Non-motor symptoms can manifest up to twenty years before the onset of classic motor symptoms.
- Current diagnostic criteria for PD now incorporate non-motor features.
Conclusions:
- Increased public awareness and early detection of PD are vital.
- Timely neuroprotective interventions can significantly enhance the quality of life for individuals with PD.
- Urgent measures are needed to counteract the rising global prevalence of Parkinson's disease.
Keywords:
Parkinson’s diseaseTransylvania regionepidemiologyquality of lifestudy sample characteristicsMore Related Videos
Related Concept Videos
Parkinson's Disease: Overview
805
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
805
Parkinson's Disease: Treatment
429
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
429


